Trump Announces 100% Tariffs on Generic Drugs to Boost US Production
- Donald Trump has announced the imposition of 100% tariffs on generic medicines imported into the United States, effective August 2028.
- The announcement has triggered immediate reactions from European leaders and healthcare officials.
- The proposed tariffs aim to shift the pharmaceutical supply chain away from global hubs and back to American soil.
Donald Trump has announced the imposition of 100% tariffs on generic medicines imported into the United States, effective August 2028. According to reports from BFM and Sud Ouest, the measure is designed to force the relocalization of pharmaceutical production within the U.S. by making foreign imports cost-prohibitive.
The announcement has triggered immediate reactions from European leaders and healthcare officials. In Belgium, Maxime Prévot denounced the move as a risk for patients
, according to RTL Info. The policy targets generic drugs, which are lower-cost versions of brand-name medications, creating a fiscal ultimatum for international pharmaceutical manufacturers.
The proposed tariffs aim to shift the pharmaceutical supply chain away from global hubs and back to American soil. By implementing a 100% tax on these imports, the administration seeks to incentivize companies to build or expand manufacturing facilities inside the United States to avoid the levy.
European Response and Diplomatic Coordination
European capitals are coordinating a joint response to the trade threat. According to Les Echos, Berlin and Brussels are forming a united front to oppose the offensive.
The Belgian government’s concern, as reported by RTL Info, focuses specifically on patient access.
Timeline and Implementation of the 100% Tariffs
The tariffs are not scheduled for immediate implementation. BFM reports that the 100% duties will take effect in August 2028.
Sud Ouest characterizes the move as a fiscal ultimatum.